Telisa

Telmisartan USP

CARDIOVASCULAR

INDICATION

Telisa is indicated for

• Hypertension
• Hypertension with CV risk

DOSAGE AND ADMINISTRATION

Hypertension
Dosage must be individualized. The usual starting dose of Telisa tablets is 40 mg once a day. Blood pressure response is dose-related over the range of 20 to 80 mg. Most of the antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks. When additional blood pressure reduction beyond that achieved with 80 mg Telisa is required, a diuretic may be added. No initial dosage adjustment is necessary for elderly patients or patients with renal impairment, including those on hemodialysis.

Cardiovascular Risk Reduction
The recommended dose of Telisa tablets is 80 mg once a day and can be administered with or without food. It is not known whether doses lower than 80 mg of Telmisartan are effective in reducing the risk of cardiovascular morbidity and mortality. When initiating Telmisartan therapy for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary.

OR, AS DIRECTED BY PHYSICIAN.

COMPOSITION

Telisa 40 Tablet: Each tablet contains Telmisartan USP 40 mg.
Telisa 80 Tablet: Each tablet contains Telmisartan USP 80 mg.